Advertisement
Screener

ELEVANCE HEALTH, INC. (ELV) Deferred Foreign Income Tax Expense (Benefit)

2.8 / 5 stars · 66/120 Roast Me

ELEVANCE HEALTH, INC. Deferred Foreign Income Tax Expense (Benefit)

ELEVANCE HEALTH, INC. (ELV) reported Deferred Foreign Income Tax Expense (Benefit) of -$180.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-06

  • ELEVANCE HEALTH, INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$180.00M.
  • ELEVANCE HEALTH, INC. deferred foreign income tax expense (benefit) for fiscal 2024 was -$134.00M.
  • ELEVANCE HEALTH, INC. deferred foreign income tax expense (benefit) for fiscal 2023 was -$167.00M.
Period endDeferred Foreign Income Tax Expense (Benefit) 12 month
2025-12-31-$180.00M
10-K · filed 2026-02-06
2024-12-31-$134.00M
10-K · filed 2026-02-06
2023-12-31-$167.00M
10-K · filed 2026-02-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cigna Group (CI)United States$70.160B10.44
HUMANA INC (HUM)United States$45.651B18.44
CENTENE CORP (CNC)United States$30.588B-6.22
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
Alignment Healthcare, Inc. (ALHC)United States$1.593B121.28
TRUPANION, INC. (TRUP)United States$0.984B
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62